The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-12 of 12 articles
Applied coronary physiology for planning and guidance of percutaneous coronary interventions. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the European Society of Cardiology
Escaned J,
Berry C,
De Bruyne B,
Shabbir A,
Collet C,
Lee JM,
Appelman Y,
Barbato E,
Biscaglia S,
Buszman P,
Campo G,
Chieffo A,
Colleran R,
Collison D,
Davies J,
Giacoppo D,
Holm N,
Jeremias A,
Paradies V,
Piróth Z,
Raposo L,
Roguin A,
Rudolph T,
Sarno G,
Sen S,
Toth G,
Van Belle E,
Zimmermann F,
Dudek D,
Stefanini G,
Tarantini G
May 12, 2023 | 10.4244/EIJ-D-23-00194
Quantitative flow ratio versus fractional flow reserve for guiding percutaneous coronary intervention: design and rationale of the randomised FAVOR III Europe Japan trial
Andersen B,
Sejr-Hansen M,
Westra J,
Campo G,
Efterkhari A,
Tu S,
Escaned J,
Koltowski L,
Stähli B,
Erglis A,
Jaruševičius G,
Žiubrytė G,
Råmunddal T,
Liu T,
Wijns W,
Landmesser U,
Maillard L,
Matsuo H,
Christiansen E,
Holm N
April 3, 2023 | 10.4244/EIJ-D-21-00214
Reproducibility of quantitative flow ratio: the QREP study
Westra J,
Sejr-Hansen M,
Koltowski L,
Mejía-Rentería H,
Tu S,
Kochman J,
Zhang Y,
Liu T,
Campo G,
Hjort J,
Mogensen LJH,
Erriquez A,
Andersen B,
Efterkhari A,
Escaned J,
Christiansen E,
Holm N
February 18, 2022 | 10.4244/EIJ-D-21-00425
Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial
Onuma Y,
Chevalier B,
Ono M,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabate M,
Windecker S,
Rapoza R,
West N,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Serruys P
December 4, 2020 | 10.4244/EIJ-D-20-00024
Functional assessment 3.0: from wire through angio to OCT
September 18, 2020 | 10.4244/EIJV16I7A99
Impact of Absorb bioresorbable scaffold implantation technique on post-procedural quantitative coronary angiographic endpoints in ST-elevation myocardial infarction: a sub-analysis of the BVS STEMI STRATEGY-IT study
Hioki H,
Brugaletta S,
Ishida K,
Campo G,
Biscaglia S,
Ortega-Paz L,
Cortese B,
Varricchio A,
Latib A,
Sabate M,
Tespili M,
Ielasi A
May 20, 2019 | 10.4244/EIJ-D-18-00504
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G,
Moscarella E,
Brugaletta S,
Pernigotti A,
Ortega-Paz L,
Gomez-Lara J,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Bethencourt A,
Vázquez N,
Valgimigli M,
Serruys P,
Sabate M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B,
Cequier A,
Dudek D,
Haude M,
Carrié D,
Sabate M,
Windecker S,
Reith S,
de Sousa Almeida M,
Campo G,
Iñiguez A,
Onuma Y,
Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L,
Brugaletta S,
Giacchi G,
Ishida K,
Cequier A,
Iñiguez A,
Serra A,
Jiménez-Quevedo P,
Mainar V,
Campo G,
Tespili M,
den Heijer P,
Valgimigli M,
Serruys P,
Sabate M
August 4, 2017 | 10.4244/EIJ-D-16-00512
Does the site of bleeding matter? A stratified analysis on location of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction
Vranckx P,
Campo G,
Anselmi M,
Bolognese L,
Colangelo S,
Biondi-Zoccai G,
Moreno R,
Piva T,
Favero L,
Prati F,
Nazzaro M,
Fern J,
Ferrari R,
Valgimigli M
May 15, 2012 | 10.4244/EIJV8I1A12
Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation
Varani E,
Guastaroba P,
Di Tanna G,
Saia F,
Balducelli M,
Campo G,
Vignali L,
Rossi R,
Manari A,
Piovaccari G,
De Palma R,
Marzocchi A
April 12, 2010
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry
Saia F,
Piovaccari G,
Manari A,
Guastaroba P,
Vignali L,
Varani E,
Santarelli A,
Benassi A,
Liso A,
Campo G,
Tondi S,
Tarantino F,
De Palma R,
Marzocchi A
May 19, 2009
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023